Pharmaceutical Technology® and BioPharm International® to Host 2020 Bio/Pharma Virtual Congress

·2-min read

Virtual event will explore the latest developments in formulation, manufacturing, quality and innovative drug dosage forms, as well as detailed discussions about crucial topics impacting the industry

Pharmaceutical Technology® and BioPharm International® are pleased to announce their first-ever 2020 Bio/Pharma Virtual Congress, taking place Wednesday, Nov. 11, from 8:30 a.m. to 4 p.m. EST.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201029006116/en/

"Now, more than ever, there is a need for education, as biopharmaceutical and pharmaceutical development and manufacturing have never been greater," said Mike Hennessy Jr., president and CEO of MJH Life Sciences™, parent company of Pharmaceutical Technology® and BioPharm International®. "With pandemic-related travel restrictions preventing in-person education and networking, we are excited to offer a dedicated event for bio/pharma development and manufacturing professionals to come together to connect and learn more about ways to overcome formulation, manufacturing, and quality challenges.

The 2020 Bio/Pharma Virtual Congress will consist of four interactive, educational tracks: formulation, manufacturing, drug dosage form trends, and bio/pharma industry challenges. Expert panel discussions moderated by the editors will address the impact of the pandemic on bioprocessing; quality practices including remote inspections; excipient characterization for improved formulations; and advanced technologies to monitor manufacturing processes.

James Mayne, Ph.D., vice president, science and regulatory advocacy at PhRMA, and Phyllis Arthur, vice president, infectious diseases and diagnostics policy at Biotechnology Innovation Organization, will deliver a joint keynote panel discussion titled "Bio/Pharma Industry—Beyond Politics and the Pandemic." Mayne and Arthur, and members of other industry organizations, will discuss crucial business, regulatory, and science-based issues facing the industry during the COVID-19 pandemic.

For more information and to register, click here.

About Pharmaceutical Technology®
Pharmaceutical Technology® is a multimedia platform that provides professionals in the global pharmaceutical manufacturing drug development community with dynamic and reliable, cutting-edge, peer-reviewed content and features on next-generation process development and manufacturing, formulation, drug delivery, ingredients, regulation, analytics, packaging, supply chain and outsourcing. Pharmaceutical Technology® also provides comprehensive coverage of international regulations and business trends related to drug development. Pharmaceutical Technology® is a brand of MJH Life Sciences™, the largest privately held, independent, full-service medical media company in North America.

About BioPharm International®
BioPharm International® integrates the science and business of biopharmaceutical research, development and manufacturing. BioPharm International® is a multimedia peer-reviewed resource on technical solutions to help biopharmaceutical professionals succeed in their work. This digital platform features peer-reviewed papers, technical articles, technology reports, regulatory and business columns, and expert commentary surrounding biopharmaceuticals, biotechnology, bioprocessing and all topics related to pharma manufacturing. BioPharm International® is a brand of MJH Life Sciences™, the largest privately held, independent, full-service medical media company in North America.

View source version on businesswire.com: https://www.businesswire.com/news/home/20201029006116/en/

Contacts

Pharmaceutical Technology® Media Contact
Alexandra Ventura, 609-716-7777
aventura@mjhlifesciences.com